Elevation of intraocular pressure (IOP) due to therapeutic use of glucocorticoids is called
steroid-induced ocular hypertension (SIOH); this can lead to steroid-induced glaucoma …

Glucocorticoid (GC)-induced ocular hypertension and secondary iatrogenic open-angle
glaucoma are serious side effects of GC therapy. Its clinical presentation is similar in many …

Primary open angle glaucoma (POAG) is a leading cause of visual impairment and
blindness worldwide. To date, at least 20 genetic loci for POAG have been reported. Only 3 …

Subtilase cytotoxin (SubAB) is the prototype of a new family of AB5 cytotoxins produced by
Shiga toxigenic Escherichia coli. Its cytotoxic activity is due to its capacity to enter cells and …

Background To describe the occurrence of ocular hypertension in four patients following
injection of ranibizumab intravitreally. Methods Case series. Results Four patients had high …

Glaucoma is a common, complex, heterogenous disease and it constitutes the major cause
of irreversible blindness worldwide. Primary open-angle glaucoma (POAG) is the most …

Purpose: To summarize the literature addressing sustained and delayed elevation of
intraocular pressure (IOP) in patients with neovascular age-related macular degeneration …

Background In addition to their well-documented ocular therapeutic effects, glucocorticoids
(GCs) can cause sight-threatening side-effects including ocular hypertension presumably …

v12a14-rozsa pgmkr Page 1 Molecular Vision 2006; 12:125-41 <http://www.molvis.org/molvis/v12/a14/>
Received 4 November 2005 | Accepted 16 February 2006 | Published 27 February 2006 …

Changes in the actin cytoskeleton, especially the formation of cross-linked actin networks
(CLANs) are thought to contribute to the increased intraocular pressure observed in primary …